Ak. Lehmann et al., HIGH-LEVELS OF INTERLEUKIN-10 IN SERUM ARE ASSOCIATED WITH FATALITY IN MENINGOCOCCAL DISEASE, Infection and immunity, 63(6), 1995, pp. 2109-2112
Interleukin 10 (IL-10) suppresses the production of proinflammatory cy
tokines in vitro and in murine models of endotoxemia and has been sugg
ested as a candidate for treatment of bacterial septicemia. To investi
gate the role of IL-10 in meningococcal disease, a sandwich IL-10 enzy
me-amplified sensitivity immunoassay was used to quantitate IL-10 in s
erum and cerebrospinal fluid samples from 41 patients with meningococc
al bacteremia or meningitis with or without septic shock. High levels
of IL-10 were demonstrated in sera from patients with meningococcal se
ptic shock (mean, 21,221 pg/ml; range, 25 to 64,500 pg/ml). All cases
involving fatalities had IL-10 levels in serum of greater than or equa
l to 1,000 pg/ml (mean, 23,058 pg/ml; range, 1,000 to 64,500 pg/ml). P
atients with meningococcal meningitis without septic shock had compara
bly low concentrations of IL-10 in serum (mean, 119 pg/ml; range, 0 to
1,050 pg/ml) but exhibited compartmentalized release of IL-10 in cere
brospinal fluid. Concentrations of IL-10 in serum were positively corr
elated with the previously reported concentrations of tumor necrosis f
actor alpha, IL-6, and IL-8 in serum in the same patients. We conclude
that IL-10 is extensively activated along with the proinflammatory cy
tokines during the initial phase of meningococcal septic shock and tha
t IL-10 is associated with fatality in meningococcal disease.